Metabolic Flexibility vs Unrestrained Oxidation: Therapeutic Windows for Early Heart Failure

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  The Journal of Clinical Investigation https://doi.org/10.1172/JCI202528
Dr. Chai-Wan Kim et al.

Points

Cardiomyocytes normally derive more than 70% of their metabolic energy from burning fats, but overactivating this pathway increases myocardial oxygen demand and restricts essential glucose utilization.
Genetic removal of the regulatory enzymes acetyl-CoA carboxylase 1 and 2 in mice led to unrestrained lipid burning, resulting in weakened blood-pumping function.
Advanced lipidomic analysis revealed that excessive fat burning rapidly depletes linoleic acid, a vital dietary nutrient needed to maintain structural cardiolipin within the inner mitochondrial membrane.
The subsequent reduction in cardiolipin directly impaired mitochondrial electron transport chain activity, causing cellular energy production to collapse and inducing dilated cardiomyopathy.
Early treatment with pharmacological transport inhibitors restored cardiolipin levels and normalized cardiac function, demonstrating that metabolic interventions are highly time-sensitive.

Summary

Biochemical consequences of constitutively elevated fatty acid oxidation (FAO) in cardiomyocytes and its role in provoking heart failure. Under physiological conditions, healthy myocardial tissue relies heavily on FAO, which generates more than 70% of its total cellular energy production. However, over-activating this pathway can increase myocardial oxygen demand and suppress metabolic flexibility by blocking glucose utilization via the Randle cycle. To determine whether maximizing fat burning is therapeutically viable or toxic, investigators generated cardiomyocyte-specific acetyl-CoA carboxylase 1 and 2 double-knockout (ACC dHKO) mice, establishing a model of unrestrained, unregulated lipid entry into the mitochondria.

The baseline metabolic results demonstrated that ACC dHKO mice rapidly developed dilated cardiomyopathy and structural heart failure. Lipidomic analysis revealed that hyper-activated lipid metabolism caused a marked depletion of cardiolipin, a critical structural phospholipid required to anchor the mitochondrial inner membrane. This deficiency arose because unrestrained lipid burning depleted the intracellular pools of linoleic acid, an essential dietary fatty acid needed to synthesize functional cardiolipin. Consequently, the loss of this structural lipid impaired mitochondrial electron transport chain (ETC) enzyme activity, resulting in structural mitochondrial degradation, decreased ATP generation, and progressive myocardial chamber dilation.

To evaluate potential rescue strategies, the researchers administered pharmacological FAO inhibitors, specifically etomoxir or oxfenicine, which block the carnitine palmitoyltransferase 1 (CPT1) transport protein. Early prophylactic administration of these agents before the onset of clinical cardiac dysfunction effectively restored linoleic acid levels, normalized cardiolipin structural reserves, and prevented dilated cardiomyopathy. However, the same therapeutic metabolic adjustments failed to reverse cardiac dysfunction once structural heart failure was established. These results suggest that maintaining strict metabolic flexibility is vital for long-term myocardial survival, indicating that strategies designed to broadly maximize cardiac fat burning may be detrimental rather than beneficial in heart failure management.

Link to the article: https://www.jci.org/articles/view/202528

References

Kim, C.-W., Vale, G., Fu, X., McDonald, J. G., Dai, C., Li, C., Wang, Z. V., Sharma, G., Khemtong, C., Malloy, C. R., Deja, S., Burgess, S. C., Mitsche, M. A., & Horton, J. D. (2026). Unrestrained fatty acid oxidation triggers heart failure in mice via cardiolipin loss and mitochondrial dysfunction. The Journal of Clinical Investigation, 136(9). https://doi.org/10.1172/JCI202528